AtaiBeckley (ATAI) Acquisitions (2021)
AtaiBeckley (ATAI) posted Acquisitions of $37000.0 for Q2 2021, up 270.0% sequentially from $10000.0 in Q1 2021.
Powered by 
Analysis
AtaiBeckley (ATAI) Acquisitions (2021) Analysis & Trends
AtaiBeckley has reported Acquisitions for 1 years, with the latest figure at $37000.0 in Q2 2021.
- Quarterly Acquisitions changed N/A year-over-year to $37000.0 in Q2 2021, while the trailing twelve-month figure through Mar 2022 was $37000.0 (changed N/A YoY) and the FY2024 annual result came in at $359000.0, changed N/A from the prior year.
- Acquisitions improved to $37000.0 in Q2 2021 per ATAI's latest filing, from $10000.0 in the prior quarter.
- Over five years, Acquisitions peaked at $37000.0 in Q2 2021 and troughed at $10000.0 in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | - |